Summary

The global artificial blood vessels market is set for consistent expansion, with projections indicating a rise from US$ 2.21 billion in 2025 to US$ 3.01 billion by 2032. This reflects a steady compound annual growth rate (CAGR) of 4.50% during the forecast period. The rise in cardiovascular diseases, growing geriatric population, and increasing demand for minimally invasive surgical procedures are some of the primary factors contributing to market growth.

Artificial blood vessels, widely used in vascular surgeries where native vessels are inadequate, are evolving with advancements in material science and 3D printing technology. The demand is especially driven by the need for better clinical outcomes, biocompatibility, and personalized healthcare solutions.

Market Insights

Artificial blood vessels are now more than just substitutes in complex cardiovascular surgeries—they represent the future of tailored and efficient vascular treatment. Advancements in biomaterials have led to the development of grafts that closely mimic natural blood vessels in structure and function. In tandem, 3D printing has revolutionized the ability to customize implants for individual patient anatomy, pushing the healthcare industry closer to personalized medicine.

Polyethylene terephthalate (PET) is emerging as a preferred material due to its strength, durability, and compatibility with the human body. Moreover, increased awareness and screening for cardiovascular conditions have resulted in higher surgical interventions, boosting the market’s overall momentum.

Market Drivers

The global rise in cardiovascular diseases remains the strongest catalyst for market growth. Conditions such as atherosclerosis, coronary artery disease, and peripheral artery disease are on the rise due to sedentary lifestyles, poor diets, and aging demographics. This drives the need for vascular grafts and alternative treatments like artificial blood vessels.

Additionally, the medical field’s increasing tilt towards minimally invasive surgical techniques plays a pivotal role. These procedures not only reduce recovery time and infection risks but also improve patient outcomes. Artificial blood vessels are compatible with many such procedures, making them integral to modern vascular surgeries.

Significant investment in research and development is also enhancing the performance of artificial blood vessels. Researchers are using new techniques such as tissue engineering and bioengineering to create grafts that are more effective, adaptable, and long-lasting.

Business Opportunities

Personalized medicine presents an exciting avenue for the artificial blood vessels market. As the medical field advances toward individualized treatment plans, the ability to design vascular grafts tailored to a patient's biological and anatomical characteristics is becoming a game-changer.

Innovations in 3D printing are particularly noteworthy. These allow for rapid prototyping and production of artificial blood vessels that match a patient’s requirements with high precision. Bioengineered materials that simulate real blood vessels offer improved healing and integration, opening up new possibilities for treatment and surgical success.

Furthermore, the integration of smart materials into artificial blood vessels is on the horizon. These materials are designed to respond to physiological changes, offering more dynamic support to the body and potentially revolutionizing post-surgical care and recovery.

Regional Overview

North America is poised to maintain a dominant position in the global artificial blood vessels market, supported by advanced healthcare infrastructure, robust R&D capabilities, and government-led health awareness initiatives. The presence of major market players and increasing surgical interventions related to cardiovascular diseases further strengthen its lead.

Asia Pacific is expected to grow at the fastest rate, driven by increasing incidences of heart-related ailments, rising healthcare spending, and a surge in cardiac surgeries. Ongoing research projects, such as those by the Indian Institute of Science (IISc), are also contributing significantly by developing innovative grafts that replicate real blood vessels.

Europe remains a strong player due to updated healthcare guidelines and a focus on preventative cardiovascular care. Integration of updated surgical techniques and a rising elderly population continue to boost the regional market outlook.

Key Players

The artificial blood vessels market features a competitive and dynamic Analysis. Key industry participants are prioritizing innovation, strategic partnerships, and geographical expansion. Notable companies include:

• B. Braun Melsungen

• Becton, Dickinson and Company

• Cook Medical Incorporated

• Medtronic

• LeMaitre Vascular Inc.

• Terumo Medical Corporation

• W. L. Gore and Associates

• Jotec GmbH

• Humacyte Inc.

• Techshot Inc.

These players are at the forefront of developing next-generation vascular solutions that align with the needs of modern medicine.

Recent Developments

In May 2024, engineers at Carnegie Mellon University introduced a groundbreaking method to manufacture artificial blood vessels, opening new possibilities for organ creation and disease modeling.

October 2024 saw University College London launch a 3D photoacoustic scanner for enhanced vascular imaging, allowing for real-time visualization of microvasculature in clinical settings.

Also in October 2024, KIMSHEALTH Hospital in Kerala introduced an advanced electrophysiology lab equipped with 3D mapping capabilities to improve the diagnosis and treatment of vascular disorders.

Researchers from the University of Edinburgh and Heriot-Watt University have developed artificial blood vessels using 3D printing that mimic natural vessels, eliminating the need for vein extraction in bypass surgeries.

Market Segmentation

By Polymer Type

• Polydioxanone

• Elastomer

• Polyethylene Terephthalate

• Others

By Application

• Aortic Disease

• Peripheral Artery Disease

• Hemodialysis

By End User

• Hospitals

• Cardiac Catheterization Laboratories

• Ambulatory Surgical Centers

• Specialty Clinics

• Others

By Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Artificial Blood Vessels Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Artificial Blood Vessels Market Outlook, 2019-2032
3.1. Global Artificial Blood Vessels Market Outlook, by Polymer Type, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Polydioxanone
3.1.1.2. Elastomer
3.1.1.3. Polyethylene Terephthalate
3.1.1.4. Others
3.2. Global Artificial Blood Vessels Market Outlook, by Application, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Aortic Disease
3.2.1.2. Peripheral Artery Disease
3.2.1.3. Hemodialysis
3.3. Global Artificial Blood Vessels Market Outlook, by End User, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Cardiac Catheterization Laboratories
3.3.1.3. Ambulatory Surgical Centers
3.3.1.4. Specialty Clinics
3.3.1.5. Others
3.4. Global Artificial Blood Vessels Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Artificial Blood Vessels Market Outlook, 2019-2032
4.1. North America Artificial Blood Vessels Market Outlook, by Polymer Type, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Polydioxanone
4.1.1.2. Elastomer
4.1.1.3. Polyethylene Terephthalate
4.1.1.4. Others
4.2. North America Artificial Blood Vessels Market Outlook, by Application, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Aortic Disease
4.2.1.2. Peripheral Artery Disease
4.2.1.3. Hemodialysis
4.3. North America Artificial Blood Vessels Market Outlook, by End User, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Cardiac Catheterization Laboratories
4.3.1.3. Ambulatory Surgical Centers
4.3.1.4. Specialty Clinics
4.3.1.5. Others
4.4. North America Artificial Blood Vessels Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. U.S. Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
4.4.1.2. U.S. Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
4.4.1.3. U.S. Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
4.4.1.4. Canada Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
4.4.1.5. Canada Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
4.4.1.6. Canada Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Artificial Blood Vessels Market Outlook, 2019-2032
5.1. Europe Artificial Blood Vessels Market Outlook, by Polymer Type, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Polydioxanone
5.1.1.2. Elastomer
5.1.1.3. Polyethylene Terephthalate
5.1.1.4. Others
5.2. Europe Artificial Blood Vessels Market Outlook, by Application, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Aortic Disease
5.2.1.2. Peripheral Artery Disease
5.2.1.3. Hemodialysis
5.3. Europe Artificial Blood Vessels Market Outlook, by End User, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Cardiac Catheterization Laboratories
5.3.1.3. Ambulatory Surgical Centers
5.3.1.4. Specialty Clinics
5.3.1.5. Others
5.4. Europe Artificial Blood Vessels Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Germany Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
5.4.1.2. Germany Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
5.4.1.3. Germany Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
5.4.1.4. U.K. Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
5.4.1.5. U.K. Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
5.4.1.6. U.K. Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
5.4.1.7. France Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
5.4.1.8. France Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
5.4.1.9. France Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
5.4.1.10. Italy Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
5.4.1.11. Italy Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
5.4.1.12. Italy Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
5.4.1.13. Turkey Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
5.4.1.14. Turkey Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
5.4.1.15. Turkey Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
5.4.1.16. Russia Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
5.4.1.17. Russia Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
5.4.1.18. Russia Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
5.4.1.19. Rest of Europe Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
5.4.1.20. Rest of Europe Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
5.4.1.21. Rest of Europe Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Artificial Blood Vessels Market Outlook, 2019-2032
6.1. Asia Pacific Artificial Blood Vessels Market Outlook, by Polymer Type, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Polydioxanone
6.1.1.2. Elastomer
6.1.1.3. Polyethylene Terephthalate
6.1.1.4. Others
6.2. Asia Pacific Artificial Blood Vessels Market Outlook, by Application, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Aortic Disease
6.2.1.2. Peripheral Artery Disease
6.2.1.3. Hemodialysis
6.3. Asia Pacific Artificial Blood Vessels Market Outlook, by End User, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Cardiac Catheterization Laboratories
6.3.1.3. Ambulatory Surgical Centers
6.3.1.4. Specialty Clinics
6.3.1.5. Others
6.4. Asia Pacific Artificial Blood Vessels Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. China Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
6.4.1.2. China Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
6.4.1.3. China Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
6.4.1.4. Japan Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
6.4.1.5. Japan Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
6.4.1.6. Japan Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
6.4.1.7. South Korea Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
6.4.1.8. South Korea Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
6.4.1.9. South Korea Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
6.4.1.10. India Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
6.4.1.11. India Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
6.4.1.12. India Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
6.4.1.13. Southeast Asia Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
6.4.1.14. Southeast Asia Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
6.4.1.15. Southeast Asia Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
6.4.1.16. Rest of Asia Pacific Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
6.4.1.17. Rest of Asia Pacific Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
6.4.1.18. Rest of Asia Pacific Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Artificial Blood Vessels Market Outlook, 2019-2032
7.1. Latin America Artificial Blood Vessels Market Outlook, by Polymer Type, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Polydioxanone
7.1.1.2. Elastomer
7.1.1.3. Polyethylene Terephthalate
7.1.1.4. Others
7.2. Latin America Artificial Blood Vessels Market Outlook, by Application, Value (US$ Bn), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Aortic Disease
7.2.1.2. Peripheral Artery Disease
7.2.1.3. Hemodialysis
7.3. Latin America Artificial Blood Vessels Market Outlook, by End User, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Cardiac Catheterization Laboratories
7.3.1.3. Ambulatory Surgical Centers
7.3.1.4. Specialty Clinics
7.3.1.5. Others
7.4. Latin America Artificial Blood Vessels Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Brazil Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
7.4.1.2. Brazil Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
7.4.1.3. Brazil Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
7.4.1.4. Mexico Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
7.4.1.5. Mexico Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
7.4.1.6. Mexico Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
7.4.1.7. Argentina Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
7.4.1.8. Argentina Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
7.4.1.9. Argentina Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
7.4.1.10. Rest of Latin America Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
7.4.1.11. Rest of Latin America Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
7.4.1.12. Rest of Latin America Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Artificial Blood Vessels Market Outlook, 2019-2032
8.1. Middle East & Africa Artificial Blood Vessels Market Outlook, by Polymer Type, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Polydioxanone
8.1.1.2. Elastomer
8.1.1.3. Polyethylene Terephthalate
8.1.1.4. Others
8.2. Middle East & Africa Artificial Blood Vessels Market Outlook, by Application, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Aortic Disease
8.2.1.2. Peripheral Artery Disease
8.2.1.3. Hemodialysis
8.3. Middle East & Africa Artificial Blood Vessels Market Outlook, by End User, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Cardiac Catheterization Laboratories
8.3.1.3. Ambulatory Surgical Centers
8.3.1.4. Specialty Clinics
8.3.1.5. Others
8.4. Middle East & Africa Artificial Blood Vessels Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. GCC Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
8.4.1.2. GCC Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
8.4.1.3. GCC Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
8.4.1.4. South Africa Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
8.4.1.5. South Africa Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
8.4.1.6. South Africa Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
8.4.1.7. Egypt Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
8.4.1.8. Egypt Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
8.4.1.9. Egypt Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
8.4.1.10. Nigeria Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
8.4.1.11. Nigeria Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
8.4.1.12. Nigeria Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
8.4.1.13. Rest of Middle East & Africa Artificial Blood Vessels Market by Polymer Type, Value (US$ Bn), 2019-2032
8.4.1.14. Rest of Middle East & Africa Artificial Blood Vessels Market by Application, Value (US$ Bn), 2019-2032
8.4.1.15. Rest of Middle East & Africa Artificial Blood Vessels Market by End User, Value (US$ Bn), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Market Share Analysis, 2025
9.2. Competitive Dashboard
9.3. Company Profiles
9.3.1. Medtronic
9.3.1.1. Company Overview
9.3.1.2. Product Portfolio
9.3.1.3. Financial Overview
9.3.1.4. Business Strategies and Development
9.3.2. Jotec GmbH
9.3.2.1. Company Overview
9.3.2.2. Product Portfolio
9.3.2.3. Financial Overview
9.3.2.4. Business Strategies and Development
9.3.3. LeMaitre Vascular Inc.
9.3.3.1. Company Overview
9.3.3.2. Product Portfolio
9.3.3.3. Financial Overview
9.3.3.4. Business Strategies and Development
9.3.4. Humacyte Inc.
9.3.4.1. Company Overview
9.3.4.2. Product Portfolio
9.3.4.3. Financial Overview
9.3.4.4. Business Strategies and Development
9.3.5. Cook Medical Incorporated
9.3.5.1. Company Overview
9.3.5.2. Product Portfolio
9.3.5.3. Financial Overview
9.3.5.4. Business Strategies and Development
9.3.6. Techshot Inc.
9.3.6.1. Company Overview
9.3.6.2. Product Portfolio
9.3.6.3. Financial Overview
9.3.6.4. Business Strategies and Development
9.3.7. W. L. Gore and Associates
9.3.7.1. Company Overview
9.3.7.2. Product Portfolio
9.3.7.3. Financial Overview
9.3.7.4. Business Strategies and Development
9.3.8. Terumo Medical Corporation
9.3.8.1. Company Overview
9.3.8.2. Product Portfolio
9.3.8.3. Financial Overview
9.3.8.4. Business Strategies and Development
9.3.9. Braun Melsungen
9.3.9.1. Company Overview
9.3.9.2. Product Portfolio
9.3.9.3. Financial Overview
9.3.9.4. Business Strategies and Development
9.3.10. Becton
9.3.10.1. Company Overview
9.3.10.2. Product Portfolio
9.3.10.3. Financial Overview
9.3.10.4. Business Strategies and Development
9.3.11. Dickinson and Company
9.3.11.1. Company Overview
9.3.11.2. Product Portfolio
9.3.11.3. Financial Overview
9.3.11.4. Business Strategies and Development
10.Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations